A New Startup Wants to Edit Human Embryos
Update: 2025-10-30
Description
Manhattan Genomics, a New York startup, aims to eradicate genetic diseases by editing embryos before pregnancy, sparking debate and concern. Despite potential benefits for families affected by inherited disorders, risks such as introducing new problems and ethical concerns like eugenics loom large. The company faces regulatory hurdles, with a ten-year pause on heritable gene editing recommended by experts. Manhattan Genomics plans to start with animal studies and human embryos after extensive testing, indicating gene-edited babies may still be far off.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments 
In Channel







